Eriodictyol mediated selective targeting of the TNFR1/FADD/TRADD axis in cancer cells induce apoptosis and inhibit tumor progression and metastasis
Open Access
- 21 April 2022
- journal article
- research article
- Published by Elsevier in Translational Oncology
- Vol. 21, 101433
Abstract
No abstract availableKeywords
Funding Information
- Department of Biotechnology
- Indian Council of Medical Research
- Anusandhan National Research Foundation
- University Grants Commission Department of Atomic Energy Consortium for Scientific Research
This publication has 58 references indexed in Scilit:
- Nanoparticle Delivery of Natural Products in the Prevention and Treatment of Cancers: Current Status and Future ProspectsCancers, 2011
- TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanismsCell Death & Disease, 2011
- Enhanced Intestinal Absorption of Daidzein by Borneol/Menthol Eutectic Mixture and MicroemulsionAAPS PharmSciTech, 2011
- Eriodictyol Inhibits RSK2-ATF1 Signaling and Suppresses EGF-induced Neoplastic Cell TransformationJournal of Biological Chemistry, 2011
- Anticancer drug discovery in the future: an evolutionary perspectiveDrug Discovery Today, 2009
- The Multiple Battles Fought by Anti-Apoptotic p21Cell Cycle, 2007
- β-actin is required for mitochondria clustering and ROS generation in TNF-induced, caspase-independent cell deathJournal of Cell Science, 2004
- Targeting death and decoy receptors of the tumour-necrosis factor superfamilyNature Reviews Cancer, 2002
- TNF? and the TNF receptor superfamily: Structure-function relationship(s)Microscopy Research and Technique, 2000
- The Hallmarks of CancerCell, 2000